Signature for Precise Chemosensitivity Prediction in PDAC
NCT06461598
·
clinicaltrials.gov ↗
COMPLETED
Status
365
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
Chemotherapy
Sponsor
Ruijin Hospital